Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.45 |
| ▸ | CDC25B | P30305 | 8/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.44 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17456127 | 1.00 | NT5E (0.48) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL8653096 | 0.92 | NT5E (0.43) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL8653098 | 0.92 | NT5E (0.43) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL26101393 | 0.90 | NT5E (0.44) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL2312270 | 0.90 | NT5E (0.49) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL3756881 | 0.90 | NT5E (0.43) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL27002581 | 0.90 | NT5E (0.43) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL3756883 | 0.90 | NT5E (0.43) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL24804649 | 0.89 | LMNA (0.52) | LMNAPOLBKMT2ACYP2D6CA1 | |
| SCHEMBL29865166 | 0.89 | LMNA (0.52) | LMNAPOLBKMT2ACYP2D6CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10001488-B2 | Synthesis and use of isotopically-labelled glycans | Asocación Centro de Investigación Cooperativa en Biomaterials (ES) | 2018-06-19 | — | — | US | disclosed |
| EP-2981541-B1 | SYNTHESIS AND USE OF ISOTOPICALLY-LABELLED GLYCANS | ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOP EN BIOMATERIALES (ES) | 2017-09-13 | — | — | EP | disclosed |
| US-20160025742-A1 | SYNTHESIS AND USE OF ISOTOPICALLY-LABELLED GLYCANS | ASOCACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOMATERIALES (ES) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160025742-A1 | SYNTHESIS AND USE OF ISOTOPICALLY-LABELLED GLYCANS | FUT6, FUT5, ST6GAL1 | NT5E 1127/4885PTPN1 4659/4885CDC25B 4260/4885 |
| US-10001488-B2 | Synthesis and use of isotopically-labelled glycans | FUT6, FUT5, ST6GAL1 | NT5E 1127/4885PTPN1 4659/4885CDC25B 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.